Pergolide
(UWCVGPLTGZWHGS-ZORIOUSZSA-N)
Structure
- SMILES
- CS(=O)(=O)O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
- Molecular Formula:
- C20H30N2O3S2
- Molecular Weight:
- 410.594
- Log P:
- 4.7938
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 2
- TPSA:
- 107.08
- CAS Number(s):
- 66104-23-2
Synonym(s)
1.
Pergolide
2.
Celance
3.
LY-127,809
4.
LY-127809
5.
Parkotil
6.
Pergolide Mesylate
7.
Permax
8.
Pharken
9.
LY127,809
10.
LY127809
11.
Mesylate, Pergolide
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pulmonary Hypertension | FAERS: 4 | US FAERS | |
| 2 | Retroperitoneal fibrosis | FAERS: 4 | US FAERS | |
| 3 | Aortic Valve Stenosis | FAERS: 2 | US FAERS | |
| 4 | Bronchopneumonia | FAERS: 2 | US FAERS | |
| 5 | Drug ineffective | FAERS: 2 | US FAERS | |
| 6 | Hydronephrosis | FAERS: 2 | US FAERS | |
| 7 | Medication Error | FAERS: 2 | US FAERS | |
| 8 | Pharmaceutical product complaint | FAERS: 2 | US FAERS | |
| 9 | Aortic valve calcification | FAERS: 1 | US FAERS | |
| 10 | Aortic valve sclerosis | FAERS: 1 | US FAERS | |
| 11 | Apathy | FAERS: 1 | US FAERS | |
| 12 | Benign Prostatic Hyperplasia | FAERS: 1 | US FAERS | |
| 13 | Breast hyperplasia | FAERS: 1 | US FAERS | |
| 14 | Bronchial Obstruction | FAERS: 1 | US FAERS | |
| 15 | Cardiac valve replacement complication | FAERS: 1 | US FAERS | |
| 16 | Chest Pain | FAERS: 1 | US FAERS | |
| 17 | Compulsive shopping | FAERS: 1 | US FAERS | |
| 18 | Constipation | FAERS: 1 | US FAERS | |
| 19 | Dehydration | FAERS: 1 | US FAERS | |
| 20 | Economic problem | FAERS: 1 | US FAERS | |
| 21 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 22 | Fibrosis | FAERS: 1 | US FAERS | |
| 23 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 24 | Impaired work ability | FAERS: 1 | US FAERS | |
| 25 | Lymphopenia | FAERS: 1 | US FAERS | |
| 26 | Mesothelioma | FAERS: 1 | US FAERS | |
| 27 | Mitral valve sclerosis | FAERS: 1 | US FAERS | |
| 28 | Narcolepsy | FAERS: 1 | US FAERS | |
| 29 | Obsessive-Compulsive Disorder | FAERS: 1 | US FAERS | |
| 30 | Oliguria | FAERS: 1 | US FAERS | |
| 31 | Pallor | FAERS: 1 | US FAERS | |
| 32 | Pelvic mass | FAERS: 1 | US FAERS | |
| 33 | Personality Change | FAERS: 1 | US FAERS | |
| 34 | Post procedural sepsis | FAERS: 1 | US FAERS | |
| 35 | Postrenal failure | FAERS: 1 | US FAERS | |
| 36 | Restrictive cardiomyopathy | FAERS: 1 | US FAERS | |
| 37 | Right ventricular failure | FAERS: 1 | US FAERS | |
| 38 | Scleroderma | FAERS: 1 | US FAERS | |
| 39 | Syncope | FAERS: 1 | US FAERS | |
| 40 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 41 | Tricuspid valve sclerosis | FAERS: 1 | US FAERS | |
| 42 | Abdominal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 43 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 44 | Paranoia | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Phlebitis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.